(untitled)
Simon Lovestone(Johnson & Johnson (United Kingdom))
Cited by 0
Related Papers
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
|Alzheimer s & Dementia|2021|43
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
|Alzheimer s & Dementia|2024|16
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
|Alzheimer s & Dementia|2025|0
The evolution of Alzheimer’s target identification: Towards a fusion of artificial and cellular intelligence
|The Journal of Prevention of Alzheimer s Disease|2025|0